Skin vibration sensor for monitoring eczema and psoriasis
Part of Skin clinical trials.
This study tests a new sensor that monitors skin inflammation using gentle vibrations. It aims to see if this sensor can track how well phototherapy (light treatment) works for eczema or psoriasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a moderate or severe skin condition like eczema or psoriasis.
- You are about to start phototherapy (light treatment) within the next 3 weeks.
- You are not allergic to the material Parylene-C that touches the skin.
- You do not have conditions like diabetes, a weakened immune system, or are not taking blood thinners or pregnant.
- If you can become pregnant, you agree to use effective contraception during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a tiny device that samples your skin to help doctors understand psoriasis and eczema better. It may help guide more personalized treatment for your condition.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study follows people with chronic skin conditions over time, using questionnaires and photos taken at home. It tests whether digital monitoring can improve care and help doctors track your condition between visits.
This trial tests a mobile app designed to help reduce itching and related symptoms for people with psoriasis, eczema, or chronic hives. If you have moderate to severe itch and can use an English-language app, this study might be for you.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
Hear when a new Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.